Analyze the information and social media posts to determine if the closing price of $amgn will ascend or descend at 2017-07-19. Please respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-05,-0.9,0.1,-1.3,0.8,0.8,-0.6,-0.8,-2.4,-3.3,-4.5,-5.7
2017-07-06,0.8,1.1,-0.2,-1.5,-1.5,0.6,0.7,-0.7,-1.6,-2.7,-3.9
2017-07-07,0.1,0.3,-0.5,-0.2,-0.2,0.6,0.7,-0.2,-1.2,-2.2,-3.4
2017-07-10,-0.4,0.2,-0.7,0.4,0.4,0.2,0.2,-0.3,-1.4,-2.3,-3.5
2017-07-11,0.5,0.6,-0.7,0.7,0.7,-0.4,-0.4,-0.6,-1.8,-2.7,-3.8
2017-07-12,0.3,0.6,-0.3,-0.0,-0.0,-0.5,-0.3,-0.3,-1.5,-2.3,-3.4
2017-07-13,-1.0,0.7,-1.1,1.0,1.0,-1.1,-1.2,-1.2,-2.2,-3.0,-4.0
2017-07-14,-1.0,0.3,-1.5,1.2,1.2,-1.7,-2.1,-2.3,-3.0,-3.8,-4.7
2017-07-17,-0.3,0.8,-0.4,0.2,0.2,-1.2,-2.0,-2.2,-2.7,-3.7,-4.5
2017-07-18,-0.5,0.1,-0.8,0.0,0.0,-0.8,-1.8,-2.1,-2.4,-3.4,-4.3

2017-07-05: $amgn looking healthy for possible ath test soon. |$fgen all time high! who was selling early this yr after the fantastic p3 chinese results were announced. the next $amgn in the making!|rt seekingalp
2017-07-06: rt AT_USER amgen, teva hikes show pharma can't blame rebates for all price increases: analyst  $amgn $teva|almost all my big winners last few years same playbook: little to no revenue growth sell debt
2017-07-07: follow #nasdaq 100 traders &amp; track their tweets under one watchlist $amgn $qcom  |rt AT_USER more cancer drug price hikes, incl. $amgn hiking blincyto by 8% in '17 = $14k incr. per treatment cours
2017-07-08: $chrs loses another partner on its enbrel biosimilar  $amgn|AT_USER and why commit bank to $arwr &amp; not dictate numerous terms~to a cash poor company (at the time). i agree¡­ |AT_USER yes, seemingl
2017-07-09: watching--$adbe, $amgn, $avgo &amp; $ba for breakout retest.  #gst|AT_USER AT_USER AT_USER top of thread: 4/26 sean harper $amgn r&amp;d opined, "collaboration has b¡­ |household names that have becom
2017-07-10: rt AT_USER jefferies pt's $acor $22, $fgen $50, $amgn $195, $vrtx $155, $icpt $155, $axon $40, $prta $100, $once $85|novartis' ( $nvs ) cosentyx superior to stelara in psoriasis study + news on $amgn 
2017-07-11: icymi: fda says evidence supports amgen, mylan biosimilars of roche cancer drugs  #fda #odac $amgn $myl #biosimilars|#fda grants full approval of $amgn's #blincyto in relapsed/refractory b-cell precur
2017-07-12: $amgn max pain = 172.50. maturity = 07/14/2017. previous close = 173.32.   |rt AT_USER will keep posting about $fgen story can be very confusing but all you need to know is roxadustat is about to rumb
2017-07-13: $amgn max pain is 172.50 for maturity 07/14/2017. prev close = 173.27.   |rt AT_USER $ibb $amgn $celg $gild break out. |$amgn gap fill special, if they stay w/ biotech this name needs to be on your ra
2017-07-14: rt AT_USER amgen receives fda approval for blincyto  $mrk $amgn |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ |can $imgn's lead 
2017-07-15: rt AT_USER "all incentives have a way of failing, just look at our society" #scotus justice sotomayor at sandoz v. amgen. #biosimi¡­|$amgn max pain is 165.00 for maturity 07/21/2017. prev close = 177.
2017-07-16: rt AT_USER $amgn says AT_USER gave a crl for osteoporosis drug candidate romosozumab, will supply data from two trials|rt AT_USER $amgn says AT_USER gave a crl for osteoporosis drug candidate romosozu
2017-07-17: fda issues a crl for $amgn's evenity |amgen fda letter isn¡¯t a surprise (or a concern), says jefferies - barron's $amgn |commented on spectrum pharmaceuticals: will rolontis substantially increase pr
2017-07-18: what would the web address be? $mnkd or $amgn or ???  maybe it's not there for a reason. |oppenheimer holdings, inc. reaffirms ¡°outperform¡± rating for amgen inc. $amgn |$amgn gap filled, earnings so
Answer:
Analyze the information and social media posts to determine if the closing price of $amgn will ascend or descend at 2017-07-19. Please respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-05,-0.9,0.1,-1.3,0.8,0.8,-0.6,-0.8,-2.4,-3.3,-4.5,-5.7
2017-07-06,0.8,1.1,-0.2,-1.5,-1.5,0.6,0.7,-0.7,-1.6,-2.7,-3.9
2017-07-07,0.1,0.3,-0.5,-0.2,-0.2,0.6,0.7,-0.2,-1.2,-2.2,-3.4
2017-07-10,-0.4,0.2,-0.7,0.4,0.4,0.2,0.2,-0.3,-1.4,-2.3,-3.5
2017-07-11,0.5,0.6,-0.7,0.7,0.7,-0.4,-0.4,-0.6,-1.8,-2.7,-3.8
2017-07-12,0.3,0.6,-0.3,-0.0,-0.0,-0.5,-0.3,-0.3,-1.5,-2.3,-3.4
2017-07-13,-1.0,0.7,-1.1,1.0,1.0,-1.1,-1.2,-1.2,-2.2,-3.0,-4.0
2017-07-14,-1.0,0.3,-1.5,1.2,1.2,-1.7,-2.1,-2.3,-3.0,-3.8,-4.7
2017-07-17,-0.3,0.8,-0.4,0.2,0.2,-1.2,-2.0,-2.2,-2.7,-3.7,-4.5
2017-07-18,-0.5,0.1,-0.8,0.0,0.0,-0.8,-1.8,-2.1,-2.4,-3.4,-4.3

2017-07-05: $amgn looking healthy for possible ath test soon. |$fgen all time high! who was selling early this yr after the fantastic p3 chinese results were announced. the next $amgn in the making!|rt seekingalp
2017-07-06: rt AT_USER amgen, teva hikes show pharma can't blame rebates for all price increases: analyst  $amgn $teva|almost all my big winners last few years same playbook: little to no revenue growth sell debt
2017-07-07: follow #nasdaq 100 traders &amp; track their tweets under one watchlist $amgn $qcom  |rt AT_USER more cancer drug price hikes, incl. $amgn hiking blincyto by 8% in '17 = $14k incr. per treatment cours
2017-07-08: $chrs loses another partner on its enbrel biosimilar  $amgn|AT_USER and why commit bank to $arwr &amp; not dictate numerous terms~to a cash poor company (at the time). i agree¡­ |AT_USER yes, seemingl
2017-07-09: watching--$adbe, $amgn, $avgo &amp; $ba for breakout retest.  #gst|AT_USER AT_USER AT_USER top of thread: 4/26 sean harper $amgn r&amp;d opined, "collaboration has b¡­ |household names that have becom
2017-07-10: rt AT_USER jefferies pt's $acor $22, $fgen $50, $amgn $195, $vrtx $155, $icpt $155, $axon $40, $prta $100, $once $85|novartis' ( $nvs ) cosentyx superior to stelara in psoriasis study + news on $amgn 
2017-07-11: icymi: fda says evidence supports amgen, mylan biosimilars of roche cancer drugs  #fda #odac $amgn $myl #biosimilars|#fda grants full approval of $amgn's #blincyto in relapsed/refractory b-cell precur
2017-07-12: $amgn max pain = 172.50. maturity = 07/14/2017. previous close = 173.32.   |rt AT_USER will keep posting about $fgen story can be very confusing but all you need to know is roxadustat is about to rumb
2017-07-13: $amgn max pain is 172.50 for maturity 07/14/2017. prev close = 173.27.   |rt AT_USER $ibb $amgn $celg $gild break out. |$amgn gap fill special, if they stay w/ biotech this name needs to be on your ra
2017-07-14: rt AT_USER amgen receives fda approval for blincyto  $mrk $amgn |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ |can $imgn's lead 
2017-07-15: rt AT_USER "all incentives have a way of failing, just look at our society" #scotus justice sotomayor at sandoz v. amgen. #biosimi¡­|$amgn max pain is 165.00 for maturity 07/21/2017. prev close = 177.
2017-07-16: rt AT_USER $amgn says AT_USER gave a crl for osteoporosis drug candidate romosozumab, will supply data from two trials|rt AT_USER $amgn says AT_USER gave a crl for osteoporosis drug candidate romosozu
2017-07-17: fda issues a crl for $amgn's evenity |amgen fda letter isn¡¯t a surprise (or a concern), says jefferies - barron's $amgn |commented on spectrum pharmaceuticals: will rolontis substantially increase pr
2017-07-18: what would the web address be? $mnkd or $amgn or ???  maybe it's not there for a reason. |oppenheimer holdings, inc. reaffirms ¡°outperform¡± rating for amgen inc. $amgn |$amgn gap filled, earnings so
Answer:+Rise